Journals / Retina-Vitreus / 2016 / Cilt: 24 - Sayı: 3

Adult Onset Foveomacular Vitelliform Dystrophy: A Case Report

Erişkin Tip Foveomaküler Vitelliform Distrofili Bir Olgu Sunumu

Pages
242–244
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Any treatment wasn't applied to patient and he was called to follow properly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:52 years female patient came to our clinic complaints with blurred vision and vision loss for the last few months.
📊
Key Findings & Data:Visual acuity was detected 0.4 and 0.1 snellen scale at her right and left eye respectively.
💡
Conclusion & Impact:Any treatment wasn't applied to patient and he was called to follow properly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

52 years female patient came to our clinic complaints with blurred vision and vision loss for the last few months. Visual acuity was detected 0.4 and 0.1 snellen scale at her right and left eye respectively. Slitlamp evaluation revealed normal anterior segments. Fundoscopic examination showed spotted atrophic areas and beaten egg-like appearance at the lower border of the round sharp macular lesion. Hyporeflective area was detected under the neurosensorial retina at RPE level with OCT in both eyes. With these clinical findings patient was diagnosed as adult onset vitelliform dystrophy. Any treatment wasn't applied to patient and he was called to follow properly.

Özet

52 yaşında kadın hasta son birkaç aydır her iki gözde başlayan bulanık görme ve görme azlığı şikayeti ile kliniğimize başvurdu. Görme düzeyleri snellen eşeli ile sağ gözde 0.4 sol gözde 0.1 olarak tespit edildi. Ön segment muayenesi her iki gözde doğaldı. Fundus muayenesinde makulada yuvarlak keskin sınırlı lezyon içerisinde yer yer lekeli atrofik alanlar ve lezyonun alt sınırında çırpılmış yumurta benzeri görünüm mevcuttu. Optik koherens tomografide her iki göz makulada nörosensöryel retina altında RPE düzeyinde hiporeflektif bölge tespit edildi. Mevcut bulgular ile hastada erişkin tip foveomaküler vitelliform distrofisi olduğu düşünüldü. Hastaya herhangi bir tedavi uygulanmadı ve takip önerildi.

🔖

Cite This Article

ERAYDIN, B., KOÇAK, N., SÜLLÜ, Y. (2016). Adult Onset Foveomacular Vitelliform Dystrophy: A Case Report. Retina-Vitreus, Cilt: 24 - Sayı: 3, 242–244. https://ajindex.com/articles/307626

References (10)

  1. Mohler CW, Fine SL. Long-term evaluation of patients with Best's vi- telliform dystrophy. Ophthalmology. 1981;88:688-92.
  2. Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene res- ponsible for Best macular dystrophy. Nat Genet. 1998; 19:241-47.
  3. Marmorstein AD, Marmorstein LY, Rayborn M, et al. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), loca- lizes to the basolateral plasma membrane of the retinal pigment epithe- lium. Proc Natl Acad Sci U S A. 2000;97:12758-63.
  4. Brecher R, Bird AC. Adult vitelliform macular dystrophy. Eye. 1990;4:210-5.
  5. Greaves AH, Sarks JP, Sarks SH. Adult vitelliform macular degenerati- on: a clinical spectrum. Aust N Z J Ophthalmol. 1990;18:171-8.
  6. Renner AB, Tillack H, Kraus H, et al. Morphology and function- al cha- racteristics in adult vitelliform macular dystrophy. Retina. 2004;24:929-39.
  7. Hazırolan D, Unlu N, Uney GO, et al. Ranibizumab Application in An Adult-Onset Foveomacular Vitelliform Dystrophy Case. Ret-Vit. 2011;19:31-3.
  8. Gallego PR, Dolz MR, Pardo LD, et al.: Primary intravitreal ranibizu- mab for adult-onset foveomacular vitelliform dystrophy. Graefes Arch Clin Exp Ophthalmol. 2011;249:455-458.
  9. Andrade RE, Farah ME, Cardillo JA, et al. Optical coherence tomog- raphy in choroidal neovascular membrane associated with Best's vitel- liform dystrophy. Acta Ophthalmol Scand. 2002;80:216-8.
  10. Lee JY, Lim J, Chung H, et al. Spectral domain optical co- herence tomography in a patient with adult-onset vitelliform dys- trophy tre- ated with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2009;40:319-21.